Susquehanna International Group, LLP Dyne Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 154,354 shares of DYN stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,354
Previous 79,514
94.12%
Holding current value
$1.59 Million
Previous $1.87 Million
13.83%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$106 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$99.8 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$93.8 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$76.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$75.9 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $532M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...